These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 17341899)

  • 1. Effects of the anti-epidermal growth factor receptor antibody cetuximab on cholangiocarcinoma of the liver.
    Huang TW; Wang CH; Hsieh CB
    Onkologie; 2007 Mar; 30(3):129-31. PubMed ID: 17341899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of liver transplantation in the treatment of cholangiocarcinoma.
    Singal A; Welling TH; Marrero JA
    Expert Rev Anticancer Ther; 2009 Apr; 9(4):491-502. PubMed ID: 19374602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dramatic response to trastuzumab and paclitaxel in a patient with human epidermal growth factor receptor 2-positive metastatic cholangiocarcinoma.
    Law LY
    J Clin Oncol; 2012 Sep; 30(27):e271-3. PubMed ID: 22851567
    [No Abstract]   [Full Text] [Related]  

  • 4. Cholangiocarcinoma and the role of radiation and chemotherapy.
    Price P
    Hepatogastroenterology; 2001; 48(37):51-2. PubMed ID: 11268997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arterial chemotherapy and conformal radiation abolish malignant biliary obstruction.
    Guan YS; Qing He ; Ping Li ; Fu YC; Zhao SW
    Integr Cancer Ther; 2008 Mar; 7(1):51-3. PubMed ID: 18292595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proximal biliary tumors.
    Brown KM; Geller DA
    Surg Clin North Am; 2014 Apr; 94(2):311-23. PubMed ID: 24679423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late recurrence after surgery for cholangiocarcinoma: implications for follow-up?
    Thomas H; Heaton ND
    Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):544-6. PubMed ID: 18842505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective treatment of advanced cholangiocarcinoma by hepatic arterial infusion chemotherapy combination with sorafenib: one case report from China.
    Qun W; Tao Y
    Hepatogastroenterology; 2010; 57(99-100):426-9. PubMed ID: 20698202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiotherapy and multimodality management of cholangiocarcinoma.
    Urego M; Flickinger JC; Carr BI
    Int J Radiat Oncol Biol Phys; 1999 Apr; 44(1):121-6. PubMed ID: 10219804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular complications after orthotopic liver transplantation after neoadjuvant therapy for hilar cholangiocarcinoma.
    Mantel HT; Rosen CB; Heimbach JK; Nyberg SL; Ishitani MB; Andrews JC; McKusick MA; Haddock MG; Alberts SR; Gores GJ
    Liver Transpl; 2007 Oct; 13(10):1372-81. PubMed ID: 17427173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The multidisciplinary management of gastrointestinal cancer. Biliary tract cancers: from pathogenesis to endoscopic treatment.
    Demols A; Maréchal R; Devière J; Van Laethem JL
    Best Pract Res Clin Gastroenterol; 2007; 21(6):1015-29. PubMed ID: 18070701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary experience of cetuximab in the treatment of advanced-stage biliary tract cancer.
    Chang PY; Cheng MF; Lee HS; Hsieh CB; Yao NS
    Onkologie; 2010; 33(1-2):45-7. PubMed ID: 20164661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral cholangiocarcinoma with thoracic spine metastasis: a successful surgically treated case.
    Yeh CN; Chen MF; Chen TC; Tseng JH
    Int Surg; 2001; 86(4):225-8. PubMed ID: 12056466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case report--intrahepatic arterial infusion with CDDP and S-1 administration can elicit long-term survival for the patient with recurrenced intrahepatic cholangiocarcinoma after resection].
    Tanida T; Tanemura M; Kobayashi S; Wada H; Marubashi S; Eguchi H; Takeda Y; Umeshita H; Mori M; Doki Y; Nagano H
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2729-31. PubMed ID: 21224694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significant response to anti-PD-1 based immunotherapy plus lenvatinib for recurrent intrahepatic cholangiocarcinoma with bone metastasis: A case report and literature review.
    Chen WX; Li GX; Hu ZN; Zhu P; Zhang BX; Ding ZY
    Medicine (Baltimore); 2019 Nov; 98(45):e17832. PubMed ID: 31702638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical presentation and management of intrahepatic cholangiocarcinoma.
    Farges O; Fuks D
    Gastroenterol Clin Biol; 2010 Mar; 34(3):191-9. PubMed ID: 20202770
    [No Abstract]   [Full Text] [Related]  

  • 17. [A case report: successful resection of advanced intrahepatic cholangiocarcinoma responding to preoperative hepatic artery infusion of 5-FU].
    Hasuike Y; Motoori M; Hattori T; Fujita J; Mishima H; Sawamura T; Nishishou I; Kikkawa N; Sai H; Hosoki T; Mitomo M
    Gan To Kagaku Ryoho; 1999 Oct; 26(12):1909-12. PubMed ID: 10560423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant photodynamic therapy as a new approach to treating hilar cholangiocarcinoma: a phase II pilot study.
    Wiedmann M; Caca K; Berr F; Schiefke I; Tannapfel A; Wittekind C; Mössner J; Hauss J; Witzigmann H
    Cancer; 2003 Jun; 97(11):2783-90. PubMed ID: 12767091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metastatic cholangiocarcinoma to the ovary: a case series.
    Corr BR; Mantia-Smaldone G; Cantor J; Livolsi VA; Furth E; Chu CS
    Int J Gynecol Pathol; 2013 Nov; 32(6):562-5. PubMed ID: 24071872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholangiocarcinoma: advocate an aggressive operative approach with adjuvant chemotherapy.
    Kelley ST; Bloomston M; Serafini F; Carey LC; Karl RC; Zervos E; Goldin S; Rosemurgy P; Rosemurgy AS
    Am Surg; 2004 Sep; 70(9):743-8; discussion 748-9. PubMed ID: 15481288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.